TNF Pharmaceuticals (TNFA) Competitors $0.25 -0.02 (-9.00%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsTrendsBuy This Stock TNFA vs. ARAV, MTNB, AWH, RDHL, ONVO, ENSC, THAR, PTPI, PTIX, and QLGNShould you be buying TNF Pharmaceuticals stock or one of its competitors? The main competitors of TNF Pharmaceuticals include Aravive (ARAV), Matinas Biopharma (MTNB), Aspira Women's Health (AWH), RedHill Biopharma (RDHL), Organovo (ONVO), Ensysce Biosciences (ENSC), Tharimmune (THAR), Petros Pharmaceuticals (PTPI), Protagenic Therapeutics (PTIX), and Qualigen Therapeutics (QLGN). These companies are all part of the "pharmaceutical products" industry. TNF Pharmaceuticals vs. Aravive Matinas Biopharma Aspira Women's Health RedHill Biopharma Organovo Ensysce Biosciences Tharimmune Petros Pharmaceuticals Protagenic Therapeutics Qualigen Therapeutics Aravive (NASDAQ:ARAV) and TNF Pharmaceuticals (NASDAQ:TNFA) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, dividends, media sentiment, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk. Does the media refer more to ARAV or TNFA? In the previous week, TNF Pharmaceuticals had 1 more articles in the media than Aravive. MarketBeat recorded 1 mentions for TNF Pharmaceuticals and 0 mentions for Aravive. TNF Pharmaceuticals' average media sentiment score of 1.48 beat Aravive's score of 0.00 indicating that TNF Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Aravive Neutral TNF Pharmaceuticals Positive Does the MarketBeat Community favor ARAV or TNFA? Aravive received 104 more outperform votes than TNF Pharmaceuticals when rated by MarketBeat users. CompanyUnderperformOutperformAraviveOutperform Votes10462.28% Underperform Votes6337.72% TNF PharmaceuticalsN/AN/A Which has higher valuation & earnings, ARAV or TNFA? TNF Pharmaceuticals has lower revenue, but higher earnings than Aravive. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAravive$6.99M0.42-$76.32MN/AN/ATNF PharmaceuticalsN/AN/A-$4M-$11.45-0.02 Which has more volatility and risk, ARAV or TNFA? Aravive has a beta of 2.19, suggesting that its share price is 119% more volatile than the S&P 500. Comparatively, TNF Pharmaceuticals has a beta of 2.43, suggesting that its share price is 143% more volatile than the S&P 500. Is ARAV or TNFA more profitable? Aravive's return on equity of 0.00% beat TNF Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets AraviveN/A N/A N/A TNF Pharmaceuticals N/A -180.71%-84.27% Do institutionals and insiders have more ownership in ARAV or TNFA? 35.8% of Aravive shares are owned by institutional investors. Comparatively, 9.6% of TNF Pharmaceuticals shares are owned by institutional investors. 60.4% of Aravive shares are owned by company insiders. Comparatively, 1.2% of TNF Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. SummaryAravive beats TNF Pharmaceuticals on 6 of the 10 factors compared between the two stocks. Remove Ads Get TNF Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNFA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TNFA vs. The Competition Export to ExcelMetricTNF PharmaceuticalsDiagnostic substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$677,000.00$2.28B$5.28B$7.36BDividend YieldN/A0.79%5.11%4.32%P/E Ratio-0.026.8021.6317.68Price / SalesN/A45.04371.0892.88Price / CashN/A15.7538.1534.64Price / Book0.032.886.373.94Net Income-$4M-$65.73M$3.20B$247.45M7 Day Performance-2.31%0.27%1.79%0.48%1 Month Performance-33.23%-18.48%-9.41%-7.08%1 Year PerformanceN/A-21.32%9.61%-0.35% TNF Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TNFATNF PharmaceuticalsN/A$0.25-9.0%N/AN/A$677,000.00N/A-0.026Earnings ReportPositive NewsGap UpHigh Trading VolumeARAVAraviveN/A$0.04flatN/AN/A$2.95M$6.99M0.0020High Trading VolumeMTNBMatinas BiopharmaN/A$0.58+7.4%N/AN/A$2.95M$1.10M-0.1230Gap UpAWHAspira Women's Health2.194 of 5 stars$0.10+0.9%$5.50+5,512.2%-97.2%$2.92M$9.18M-0.08110Analyst ForecastShort Interest ↓News CoverageGap UpRDHLRedHill Biopharma1.1208 of 5 stars$2.27-5.8%N/A-99.2%$2.91M$3.71M0.00210Analyst ForecastShort Interest ↓Gap UpONVOOrganovo0.4965 of 5 stars$1.67+0.3%N/A-89.8%$2.84M$122,000.00-1.9620Short Interest ↑ENSCEnsysce Biosciences0.2956 of 5 stars$1.96-3.4%N/A-78.0%$2.75M$2.23M-0.0710Short Interest ↑News CoverageTHARTharimmune2.333 of 5 stars$1.17+2.1%$17.00+1,347.4%-78.8%$2.48MN/A-0.122Short Interest ↑News CoveragePTPIPetros Pharmaceuticals0.4751 of 5 stars$0.05-3.4%N/A-94.1%$2.46M$5.11M-0.0120Short Interest ↑Gap DownPTIXProtagenic Therapeutics1.5921 of 5 stars$0.31+3.0%N/A-79.4%$2.33MN/A-0.242Short Interest ↓Positive NewsGap DownQLGNQualigen TherapeuticsN/A$3.10+3.3%N/A-79.5%$2.28M$4.98M0.0050Upcoming EarningsShort Interest ↑Gap Down Remove Ads Related Companies and Tools Related Companies Aravive Alternatives Matinas Biopharma Alternatives Aspira Women's Health Alternatives RedHill Biopharma Alternatives Organovo Alternatives Ensysce Biosciences Alternatives Tharimmune Alternatives Petros Pharmaceuticals Alternatives Protagenic Therapeutics Alternatives Qualigen Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TNFA) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredMarkets in Chaos? Here’s What to Do.Wall Street's on edge with tariffs. And volatility? It's not slowing down. You've seen the headlines… Bu...Investors Alley | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredTrump to unlock 15-figure fortune for America (May 3rd) ?Recently, President Trump decided to kill the coin, for good reason. It now costs 4 cents to make a single pen...Paradigm Press | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TNF Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TNF Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TNFA Stock Free TNFA Stock Alerts